Member of the Association of American Physicians
Andrew J. Dannenberg spends much of his time researching Internal medicine, Endocrinology, Cyclooxygenase, Cancer research and Carcinogenesis. His Internal medicine study frequently links to adjacent areas such as Oncology. His research investigates the connection between Endocrinology and topics such as Alcoholic liver disease that intersect with issues in Kupffer cell, Hepatocyte, Antioxidant and Pathogenesis.
Andrew J. Dannenberg has researched Cyclooxygenase in several fields, including Gene expression, Prostaglandin E2, Downregulation and upregulation, Molecular biology and Pharmacology. His Cancer research research includes elements of Epidermal growth factor, Cytokine, Epidermal growth factor receptor, Signal transduction and Gene product. His biological study spans a wide range of topics, including Colorectal cancer and Familial adenomatous polyposis.
Internal medicine, Endocrinology, Cancer research, Cancer and Breast cancer are his primary areas of study. His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. His Endocrinology study incorporates themes from Cyclooxygenase and Mammary gland.
Andrew J. Dannenberg focuses mostly in the field of Cyclooxygenase, narrowing it down to matters related to Molecular biology and, in some cases, Transcription. His work deals with themes such as Cell growth, Epidermal growth factor receptor, Carcinogenesis, Signal transduction and Colorectal cancer, which intersect with Cancer research. His Cancer study combines topics from a wide range of disciplines, such as Clinical trial and Pathology.
Andrew J. Dannenberg focuses on Internal medicine, Breast cancer, Cancer research, Obesity and Cancer. Andrew J. Dannenberg has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study. The Endocrinology study combines topics in areas such as Azoxymethane and Gut flora.
Andrew J. Dannenberg interconnects Physiology and White adipose tissue in the investigation of issues within Breast cancer. The study incorporates disciplines such as Cancer cell, Tumor microenvironment, Endogeny, Adipose tissue and Transcription in addition to Cancer research. His studies deal with areas such as Gerontology, Public health and Risk factor as well as Cancer.
His primary areas of study are Obesity, Internal medicine, Adipose tissue, Breast cancer and Inflammation. His Obesity research includes elements of Body mass index, Cancer, Quartile and Hazard ratio. Many of his studies on Internal medicine apply to Endocrinology as well.
His work carried out in the field of Endocrinology brings together such families of science as Carcinogenesis, Coactivator, Aromatase, Progenitor cell and Dysplasia. His Adipose tissue research is multidisciplinary, incorporating perspectives in Translational research, Vascularity, Bioinformatics, Leptin and Fibrosis. In Breast cancer, Andrew J. Dannenberg works on issues like Cancer research, which are connected to Tamoxifen, Macrophage and Phenotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
COX-2 is expressed in human pulmonary, colonic, and mammary tumors.
Robert A. Soslow;Andrew J. Dannenberg;Demaretta Rush;B. M. Woerner.
Cancer (2000)
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
Kotha Subbaramaiah;Wen Jing Chung;Pedro Michaluart;Nitin Telang.
Journal of Biological Chemistry (1998)
Cyclooxygenase-2 Expression Is Up-Regulated in Human Pancreatic Cancer
Olga N. Tucker;Andrew J. Dannenberg;Eun K. Yang;Fan Zhang.
Cancer Research (1999)
Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
Kotha Subbaramaiah;Andrew J. Dannenberg.
Trends in Pharmacological Sciences (2003)
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Georgette Chan;Jay O. Boyle;Eun K. Yang;Fan Zhang.
Cancer Research (1999)
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.
Andrew J Dannenberg;Nasser K Altorki;Jay O Boyle;Chau Dang.
Lancet Oncology (2001)
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
Masayuki Fukata;Anli Chen;Arunan S. Vamadevan;Jason Cohen.
Gastroenterology (2007)
Cyclooxygenase-2 Overexpression and Tumor Formation Are Blocked by Sulindac in a Murine Model of Familial Adenomatous Polyposis
Susan K. Boolbol;Andrew J. Dannenberg;Amy Chadburn;Charles Martucci.
Cancer Research (1996)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
Andrew J Dannenberg;Kotha Subbaramaiah.
Cancer Cell (2003)
TRANSCRIPTION OF CYCLOOXYGENASE-2 IS ENHANCED IN TRANSFORMED MAMMARY EPITHELIAL CELLS
Kotha Subbaramaiah;Nitin Telang;John T. Ramonetti;Ruriko Araki.
Cancer Research (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Cornell University
University of California, San Diego
McGill University
Memorial Sloan Kettering Cancer Center
Cornell University
Boston Children's Hospital
Memorial Sloan Kettering Cancer Center
Cornell University
University of Salzburg
Hong Kong University of Science and Technology
King Abdullah University of Science and Technology
University of Washington
Istanbul Technical University
Tulane University
University of North Carolina at Chapel Hill
University of Manchester
Bayer (Germany)
University of Belgrade
Nagasaki University
University of Hohenheim
Smithsonian Institution
National Autonomous University of Mexico
University of Ulm
Geneva College